Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.53
Delayed Data
As of Jul 31
 +0.15 / +2.35%
Today’s Change
4.40
Today|||52-Week Range
15.24
-34.37%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close6.38
Today’s open6.42
Day’s range6.42 - 6.64
Volume62,354
Average volume (3 months)133,033
Market cap$151.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-72.00%
Earnings growth (this year)+63.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+70.18%
P/E ratioNM
Price/Sales34.71
Price/Book35.87

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...+0.42+3.10%
TRGTTargacept Inc-0.02-0.81%
ISRIsoRay Inc+0.01+0.72%
NATRNatures Sunshine Pro...-0.01-0.08%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.1M
Annual profit (last year)-$9.3M
Net profit margin-226.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts